The clinical relevance of PGRN in several autoimmune and chronic diseases, including rheumatoid arthritis, inflammatory bowel disease, diabetes mellitus, and atherosclerosis, has been reported [23–26]. This evidence concerns the gene GRN and atherosclerosis.